North America life science instrumentation market was valued at $24.8 billion in 2025 and is projected to reach $43.1 billion by 2035, growing at a CAGR of 5.8% during the forecast period (2026–2035). With the rapid adoption of the precision medicine approach in North America, it is becoming a fundamental engine for the growth of life science instruments in this region. Precision medicine relies on detailed cellular profiling of patients to give tailored treatment for which creates demand for advanced mass spectrometers and high-resolution imaging systems.
Browse the full report description of “North America Life Science Instrumentation Market Size, Share & Trends Analysis Report by Technology (Chromatography, Spectroscopy, Polymerase Chain Reaction (PCR), Clinical Chemistry Analyzers, Immunoassays, Next Generation Sequencing (NGS), Flow Cytometry, Microscopy, and Others), By End-User (Pharmaceutical & Biotechnology Companies, Research Institutes, and Hospitals & Laboratories), Forecast Period (2026-2035)” of https://www.omrglobal.com/industry-reports/north-american-life-science-instrumentation-market
For instance, now doctors are using dPCR instead of traditional PCR to see if a patient’s personalized therapy actually worked or not. Notably, Precision medicine is closely linked with companion diagnostics, which is essential for identifying patients who are most likely to benefit from which specific targeted therapy, which has increased demand for high-sensitivity instruments, including digital PCR (dPCR), flow cytometers, among others, in hospital laboratories.
North America is now switching from centralized testing models to decentralized, near-patient testing systems. So, instead of shipping samples to the central hub and waiting for them, now hospitals and labs are upgrading to compact life science instruments that can sequence a patient's tumor genome in less than 24 hours on-site, which helps in performing the process quickly.
Apart from this, precision medicine emphasizes continuous monitoring to check the treatment response, for which repeated use of dPCR, NGS systems is required, which is also driving the demand for life science instruments.
Life Science Instrumentation Market: Recent Technology Launches
Industry Response
The shift towards precision therapy has made hospitals and laboratories switch to advanced life science instruments, as they are an essential part of this treatment procedure. And this is making companies also focus on developing this instrument to match the pace of industry trends.
Market Coverage
Key questions addressed by the report.
By Technology
By End-Users
North American Life Science Instrumentation Market Report Segment by Region
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/north-american-life-science-instrumentation-market